Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore

Thumbnail Image
File version
Version of Record (VoR)
Bernaitis, Nijole
Ching, Chi Keong
Teo, Siew Chong
Badrick, Tony
Davey, Andrew K
Crilly, Julia
Anoopkumar-Dukie, Shailendra
Primary Supervisor
Other Supervisors
File type(s)

BACKGROUND: Warfarin requires ongoing monitoring of the International Normalised Ratio (INR). This is because numerous factors influence the response, including drug interactions with commonly-prescribed medications, such as statins. The administration of statins with warfarin may change INR; however, there is limited information regarding the effects on warfarin control as measured by time in therapeutic range (TTR). Statins may also alter bleeds with warfarin, but there are conflicting reports demonstrating both increased and decreased bleeds, and limited data on diverse ethnic populations. Therefore, the aim of this study was to determine the effect of statin administration on warfarin control and bleeds in patients in Australia and Singapore. METHODS: Retrospective data were collected for patients on warfarin between January and June 2014 in Australia and Singapore. Patient data were used to calculate TTR and bleed events. Concurrent statin therapy was assessed and comparisons of TTR and bleed incidence were made across patient subgroups. RESULTS: Warfarin control in Australia and Singapore was not significantly affected by statins, as measured by TTR (83% and 58%, respectively), frequency of testing, and warfarin doses. In Australia, statin use did not significantly affect bleeds, whilst in Singapore the bleed incidence was significantly lower for patients on statins. CONCLUSIONS: Chronic concurrent administration of statins with warfarin does not adversely affect warfarin TTR in Australia or Singapore. In Singapore, patients on statins, compared to no statins, had a lower bleed incidence and this requires further investigation, especially given the potential genetic influences of ethnicity on both statin and warfarin metabolism.

Journal Title
Journal of Clinical Medicine
Conference Title
Book Title
Thesis Type
Degree Program
Publisher link
Patent number
Grant identifier(s)
Rights Statement
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Rights Statement
Item Access Status
Access the data
Related item(s)
Clinical sciences
Biomedical and clinical sciences
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
warfarin: statins
Persistent link to this record
Bernaitis, N; Ching, CK; Teo, SC; Badrick, T; Davey, AK; Crilly, J; Anoopkumar-Dukie, S, Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore, Journal of Clinical Medicine, 2018, 7 (5), pp. 97:1-97:9